The Latest Cardiac and Vascular News
IRVINE, Calif.–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) announced today that continuous RRp® (respiration rate from the photoplethysmograph) monitoring of adult and pediatric patients with Rad-97®, Radical-7®, and Radius-7® Pulse CO-Oximeters® has received FDA clearance. With this clearance, both continuous and spot-check RRp are now available in the US, supported in a variety of pulse oximetry sensors […]
Phase 2 trial will test the unique multi-channel ion blocker in acute atrial fibrillation SAN DIEGO, Feb. 28, 2020 /PRNewswire/ — HUYA Bioscience International, the leader in accelerating global development of China’s pharmaceutical innovations, has presented the results of a Phase I study of HBI-3000, a novel drug for cardioversion of atrial fibrillation (AF). […]
LONG BEACH, Calif., Feb. 27, 2020 /PRNewswire/ — The MemorialCare Heart & Vascular Institute at Long Beach Medical Center is the only hospital in Southern California — and one of only four sites in all of California — participating in the Dual Epicardial and Endocardial Procedure clinical trial (DEEP). The trial is a prospective, multi-center, single-arm, investigational device […]
Resuscitation programs and education for fire service leaders are central elements to improve survival rates DALLAS, Feb. 27, 2020 /PRNewswire/ — The American Heart Association states more than 350,000 out-of-hospital cardiac arrests occur in the United States annually. About 90% of people who experience an out-of-hospital cardiac arrest die. A time-critical, life-threatening condition, out-of-hospital cardiac arrest […]
ENGLEWOOD, Colo., Feb. 25, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced the U.S. Food and Drug Administration (“FDA”) granted 510(k) clearance for sale in the U.S. for […]
Johnson & Johnson, in collaboration with Apple, is offering eligible U.S. adults 65 years and older the opportunity to join the clinical study by downloading the Heartline Study app on iPhone Study aims to assess whether the Heartline Study app on iPhone, and the ECG app and irregular rhythm notification […]
The company expands its personalized, mobile ECG now to over 25 countries around the world MEXICO CITY and MOUNTAIN VIEW, Calif., Feb. 19, 2020 /PRNewswire/ — AliveCor, the leader in AI-based, personal ECG technology, and provider of enterprise cardiology solutions, announced approval from the Federal Commission for the Protection against Sanitary Risk (COFEPRIS), to launch KardiaMobile in Mexico. […]
Complete reference design saves up to 6 months in development cycle for health-monitoring wearables SAN JOSE, Calif., Feb. 19, 2020 /PRNewswire/ — Blood-oxygen saturation (SpO2), an indicator of oxygen levels in capillary blood, provides a wealth of insights into a person’s well-being. Coupled with other vital signs, SpO2 offers clues into areas […]
WESTPORT, Feb. 19, 2020 (GLOBE NEWSWIRE) — Commercialization and install plan ahead of schedule Installations at new centers are driving patient enrollments and clinical data collection BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal […]
CHARLOTTE, N.C.–(BUSINESS WIRE)–Premier Inc. (NASDAQ: PINC), through its ProvideGx™ program, has partnered with Pfizer Inc. to supply Corvert® (ibutilide fumarate injection) and Vincristine Sulfate Injection, USP, to healthcare providers, to help stabilize the long-term supply of two vital medications for its members. Corvert is an anti-arrhythmic heart medication used to treat […]
